GLP1R and Hyperglycemia: In this light, antidiabetic drugs with incretin-based mechanisms of action, such as GLP-1 receptor agonists (GLP-1 RAs) and dipeptidyl peptidase-4 inhibitors (DPP-4i), have been demonstrated to be effective in treating PAS-induced hyperglycaemia [66].